Chemical tools in chromatin research

Journal of Peptide Science

Volumn 16, Issue 10, 2010, Pages 530-537

  Schwarzer, Dirk ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Chemical biology; Chemical tools; Chromatin; Histones; Protein acetylation; Protein methylation; Protein phosphorylation

Indexed keywords

DNA; HISTONE;

CHROMATIN; GENE ACTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW;

AMINO ACID SEQUENCE; CHROMATIN; DNA; GENE EXPRESSION REGULATION; HISTONES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NUCLEOSOMES; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EUKARYOTA;

EID: 78149379276     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1226     Document Type: Review

References (85)

1. Kornberg RD. Structure of chromatin. Annu. Rev. Biochem. 1977; 46: 931-954.
2. Pederson DS, Thoma F, Simpson RT. Core particle, fiber, and transcriptionally active chromatin structure. Annu. Rev. Cell. Biol. 1986; 2: 117-147.
3. Passarge E. Emil Heitz and the concept of heterochromatin: longitudinal chromosome differentiation was recognized fifty years ago. Am. J. Hum. Genet. 1979; 31: 106-115.
4. Hennig W. Heterochromatin. Chromosoma 1999; 108: 1-9.
5. Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389: 251-260.
6. Garcia-Ramirez M, Dong F, Ausio J. Role of the histone "tails" in the folding of oligonucleosomes depleted of histone H1. J. Biol. Chem. 1992; 267: 19587-11995.
7. Sandman K, Reeve JN. Archaeal chromatin proteins: different structures but common function? Curr. Opin. Microbiol. 2005; 8: 656-661.
8. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705.
9. Gershey EL, Vidali G, Allfrey VG. Chemical studies of histone acetylation. The occurrence of epsilon-N-acetyllysine in the f2a1 histone. J. Biol. Chem. 1968; 243: 5018-5022.
10. Murray K. The occurrence of epsilon-N-methyl lysine in histones. Biochemistry 1964; 3: 10-15.
11. Gutierrez RM, Hnilica LS. Tissue specificity of histone phosphorylation. Science 1967; 157: 1324-1325.
12. Smith BC, Denu JM. Chemical mechanisms of histone lysine and arginine modifications. Biochim. Biophys. Acta. 2009; 1789: 45-57.
13. Smtih DL, Bruegger BB, Halpern RM, Smith RA. New histone kinases in nuclei of rat tissues. Nature 1973; 246: 103-104.
14. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 2006; 75: 243-269.
15. Hilz H, Stone P. Poly(ADP-ribose) and ADP-ribosylation of proteins. Rev. Physiol. Biochem. Pharmacol. 1976; 76: 1-58.
16. Fischle W. Talk is cheap-cross-talk in establishment, maintenance, and readout of chromatin modifications. Genes Dev. 2008; 22: 3375-3382.
17. Wolffe AP, Guschin D. Review: chromatin structural features and targets that regulate transcription. J. Struct. Biol. 2000; 129: 102-122.
18. Lee DY, Hayes JJ, Pruss D, Wolffe AP. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 1993; 72: 73-84.
19. Johansen KM, Johansen J. Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res. 2006; 14: 393-404.
20. Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 2001; 292: 110-113.
21. Strahl BD, Ohba R, Cook RG, Allis CD. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 14967-14972.
22. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403: 41-45.
23. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293: 1074-1080.
24. Dion MF, Altschuler SJ, Wu LF, Rando OJ. Genomic characterization reveals a simple histone H4 acetylation code. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 5501-5506.
25. Henikoff S. Histone modifications: combinatorial complexity or cumulative simplicity?. Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 5308-5309.
26. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 2007; 14: 1025-1040.
27. Mujtaba S, Zeng L, Zhou MM. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 2007; 26: 5521-5527.
28. Yang XJ. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 2004; 26: 1076-1087.
29. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999; 399: 491-496.
30. Owen DJ, Ornaghi P, Yang JC, Lowe N, Evans PR, Ballario P, Neuhaus D, Filetici P, Travers AA. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 2000; 19: 6141-6149.
31. Morinière J, Rousseaux S, Steuerwald U, Soler-López M, Curtet S, Vitte AL, Govin J, Gaucher J, Sadoul K, Hart DJ, Krijgsveld J, Khochbin S, Müller CW, Petosa C. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature 2009; 461: 664-668.
32. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001; 410: 116-120.
33. Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410: 120-124.
34. Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev. 2003; 17: 1870-1881.
35. Hughes RM, Wiggins KR, Khorasanizadeh S, Waters ML. Recognition of trimethyllysine by a chromodomain is not driven by the hydrophobic effect. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 11184-11188.
36. Li H, Fischle W, Wang W, Duncan EM, Liang L, Murakami-Ishibe S, Allis CD, Patel DJ. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger. Mol. Cell. 2007; 28: 677-691.
37. Winter S, Simboeck E, Fischle W, Zupkovitz G, Dohnal I, Mechtler K, Ammerer G, Seiser C. 14-3-3 proteins recognize a histone code at histone H3 and are required for transcriptional activation. EMBO J. 2008; 27: 88-99.
38. Winter S, Fischle W, Seiser C. Modulation of 14-3-3 interaction with phosphorylated histone H3 by combinatorial modification patterns. Cell Cycle 2008; 7: 1336-1342.
39. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005; 123: 1213-1226.
40. Biel M, Wascholowski V, Giannis A. Epigenetics-an epicenter of gene regulation: histones and histone-modifying enzymes. Angew. Chem. Int. Ed. Engl. 2005; 44: 3186-3216 (Epigenetik-ein Epizentrum der Genregulation: histone und histonmodifizierende enzyme. Angew. Chem. 2005; 117: 3248-3280).
41. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu. Rev. Biochem. 2001; 70: 81-120.
42. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, Allis CD. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996; 84: 843-851.
43. Georgakopoulos T, Thireos G. Two distinct yeast transcriptional activators require the function of the GCN5 protein to promote normal levels of transcription. EMBO J. 1992; 11: 4145-4152.
44. Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 2004; 338: 17-31.
45. Tanner KG, Landry J, Sternglanz R, Denu JM. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 14178-14182.
46. Aye DE. Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell. Biol. 1999; 9: 193-198.
47. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, Jenuwein T. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593-599.
48. Wallrath LL. Unfolding the mysteries of heterochromatin. Curr. Opin. Genet. Dev. 1998; 8: 147-153.
49. Dillon SC, Zhang X, Trievel RC, Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005; 6: 227.
50. Ng HH, Feng Q, Wang H, Erdjument-Bromage H, Tempst P, Zhang Y, Struhl K. Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev. 2002; 16: 1518-1527.
51. Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437: 432-435.
52. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941-953.
53. Culhane JC, Cole PA. LSD1 and the chemistry of histone demethylation. Curr. Opin. Chem. Biol. 2007; 11: 561-568.
54. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439: 811-816.
55. Bannister AJ, Kouzarides T. Reversing histone methylation. Nature 2005; 436: 1103-1106.
56. Hsu JY, Sun ZW, Li X, Reuben M, Tatchell K, Bishop DK, Grushcow JM, Brame CJ, Caldwell JA, Hunt DF, Lin R, Smith MM, Allis CD. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 2000; 102: 279-291.
57. Bode AM, Dong Z. Inducible covalent posttranslational modification of histone H3. Sci STKE 2005; 2005: re4.
58. Cole PA. Chemical probes for histone-modifying enzymes. Nat. Chem. Biol. 2008; 4: 590-597.
59. Culhane JC, Szewczuk LM, Liu X, Da G, Marmorstein R, Cole PA. A mechanism-based inactivator for histone demethylase LSD1. J. Am. Chem. Soc. 2006; 128: 4536-4537.
60. Binda C, Hubálek F, Li M, Herzig Y, Sterling J, Edmondson DE, Mattevi A. Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class. J. Med. Chem. 2004; 47: 1767-1774.
61. Forneris F, Binda C, Vanoni MA, Battaglioli E, Mattevi A. Human histone demethylase LSD1 reads the histone code. J. Biol. Chem. 2005; 280: 41360-41365.
62. Szewczuk LM, Culhane JC, Yang M, Majumdar A, Yu H, Cole PA. Mechanistic analysis of a suicide inactivator of histone demethylase LSD1. Biochemistry 2007; 46: 6892-6902.
63. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994; 266: 776-779.
64. Muir TW, Sondhi D, Cole PA. Expressed protein ligation: a general method for protein engineering. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 6705-6710.
65. Recent review articles on protein semisynthesis: Muralidharan V, Muir TW. Protein ligation: an enabling technology for the biophysical analysis of proteins. Nat. Methods. 2006; 3: 429-438; Durek T, Becker CF. Protein semi-synthesis: new proteins for functional and structural studies. Biomol. Eng. 2005; 22: 153-172; Hackenberger CP, Schwarzer D. Chemoselective ligation and modification strategies for peptides and proteins. Angew. Chem. Int. Ed. Engl. 2008; 47: 10030-10074; Chemoselektive Ligations und modifikationsstrategien für peptide und proteine. Angew. Chem. 2008; 120: 10182-10228.
66. Shogren-Knaak MA, Fry CJ, Peterson CL. A native peptide ligation strategy for deciphering nucleosomal histone modifications. J. Biol. Chem. 2003; 278: 15744-15748.
67. He S, Bauman D, Davis JS, Loyola A, Nishioka K, Gronlund JL, Reinberg D, Meng F, Kelleher N, McCafferty DG. Facile synthesis of site-specifically acetylated and methylated histone proteins: reagents for evaluation of the histone code hypothesis. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 12033-12038.
68. Chiang KP, Jensen MS, McGinty RK, Muir TW. A semisynthetic strategy to generate phosphorylated and acetylated histone H2B. Chembiochem. 2009; 10: 2182-2187.
69. Manohar M, Mooney AM, North JA, Nakkula RJ, Picking JW, Edon A, Fishel R, Poirier MG, Ottesen JJ. Acetylation of histone H3 at the nucleosome dyad alters DNA-histone binding. J. Biol. Chem. 2009; 284: 23312-23321.
70. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006; 311: 844-847.
71. Dorigo B, Schalch T, Bystricky K, Richmond TJ. Chromatin fiber folding: requirement for the histone H4 N-terminal tail. J. Mol. Biol. 2003; 327: 85-96.
72. McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW. Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature 2008; 453: 812-816.
73. Chatterjee C, McGinty RK, Pellois JP, Muir TW. Auxiliary-mediated site-specific peptide ubiquitylation. Angew. Chem. Int. Ed. Engl. 2007; 46: 2814-2818 (Auxiliary-mediated site-specific peptide ubiquitylation. Angew. Chem. 2007; 119: 2872-2876).
74. Simon MD, Chu F, Racki LR, de la Cruz CC, Burlingame AL, Panning B, Narlikar GJ, Shokat KM. The site-specific installation of methyl-lysine analogs into recombinant histones. Cell 2007; 128: 1003-1012.
75. Lu X, Simon MD, Chodaparambil JV, Hansen JC, Shokat KM, Luger K. The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure. Nat. Struct. Mol. Biol. 2008; 15: 1122-1124.
76. Neumann H, Peak-Chew SY, Chin JW. Genetically encoding N(epsilon)-acetyllysine in recombinant proteins. Nat. Chem. Biol. 2008; 4: 232-234.
77. Nguyen DP, Garcia Alai MM, Kapadnis PB, Neumann H, Chin JW. Genetically encoding N(epsilon)-methyl-L-lysine in recombinant histones. J. Am. Chem. Soc. 2009; 131: 14194-14195.
78. Neumann H, Hancock SM, Buning R, Routh A, Chapman L, Somers J, Owen-Hughes T, van Noort J, Rhodes D, Chin JW. A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation. Mol. Cell. 2009; 36: 153-163.
79. Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996; 272: 408-411.
80. Yoshida M, Horinouchi S, Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 1995; 17: 423-430.
81. Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 1990; 265: 17174-17179.
82. Kijima M, Yoshida M, Sugita K, Horinouchi S, Beppu T. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 1993; 268: 22429-22435.
83. Newkirk TL, Bowers AA, Williams RM. Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors. Nat. Prod. Rep. 2009; 26: 1293-1320.
84. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol. Med. 2007; 13: 363-372.
85. Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 2007; 17: 195-211.